Ziyi Chen
National Key Laboratory For Multi Target Natural Drugs
Nanjing, China
Nanjing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Chromatin chronicles: Unlocking the therapeutic potential of histone modifiers in hepatocellular carcinoma.
Journal: Medical oncology (Northwood, London, England)
Published: July 11, 2025
GLIS1 intervention enhances anti-PD1 therapy for hepatocellular carcinoma by targeting SGK1-STAT3-PD1 pathway.
Journal: Journal for immunotherapy of cancer
Published: January 13, 2023
Oncoprotein SET dynamically regulates cellular stress response through nucleocytoplasmic transport in breast cancer.
Journal: Cell biology and toxicology
Published: July 15, 2022
Corrigendum to "Circ-EIF4G3 promotes the development of gastric cancer by sponging miR-335" [Pathol. - Res. Pract. 215 (2019) 152507].
Journal: Pathology, research and practice
Published: December 04, 2020
MiR-205-5p suppresses angiogenesis in gastric cancer by downregulating the expression of VEGFA and FGF1.
Journal: Experimental cell research
Published: November 07, 2020
The mechanisms of sorafenib resistance in hepatocellular carcinoma: theoretical basis and therapeutic aspects.
Journal: Signal transduction and targeted therapy
Published: January 13, 2020
Single-cell RNA sequencing of immune cells in gastric cancer patients.
Journal: Aging
Published: November 13, 2019
Star Circular RNAs In Human Cancer: Progress And Perspectives.
Journal: OncoTargets and therapy
Published: May 11, 2019
Current perspectives on the immunosuppressive tumor microenvironment in hepatocellular carcinoma: challenges and opportunities.
Journal: Molecular cancer
Published: April 27, 2019
Circ-EIF4G3 promotes the development of gastric cancer by sponging miR-335.
Journal: Pathology, research and practice
Published: April 09, 2019
Last Updated: 09/26/2026